Sai‐Juan Chen

24.3k citations

234 papers · 10.4k indexed · 4 hit papers · h-index 54

Impact in

Hematology top 0.1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Biochemistry top 0.5%
- Antioxidant Activity and Oxidative Stress

Papers in

Hematology 113
- Acute Myeloid Leukemia Research 95
- Chronic Myeloid Leukemia Treatments 23
Molecular Biology 151
- Retinoids in leukemia and cellular processes 64
- Protein Degradation and Inhibitors 23
- Epigenetics and DNA Methylation 20

Co-authors: Chen Zhu Zhu Chen Zhenyi Wang Guang‐Biao Zhou Zhixiang Shen Guoqiang Chen Shu-Min Xiong Yongmei Zhu
Journals: Blood (38 papers)Proceedings of the National Academy of Sciences (29 papers)Frontiers of Medicine (15 papers)Nature Communications (4 papers)PLoS ONE (4 papers)
Partner nations: China United States France

In The Last Decade

Sai‐Juan Chen

231 papers receiving 10.2k citations

Hit Papers

align trajectories log scale

Acute lymphoblastic leukaemia 2024 · 52 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Nature Reviews Disease Primers
2011 Nature Genetics
2005 PLoS Biology
1997 Blood

Peers

Countries citing papers authored by Sai‐Juan Chen

Since Specialization

Citations

This map shows the geographic impact of Sai‐Juan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sai‐Juan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sai‐Juan Chen more than expected).

Fields of papers citing papers by Sai‐Juan Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sai‐Juan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sai‐Juan Chen. The network helps show where Sai‐Juan Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Sai‐Juan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sai‐Juan Chen Line = papers co-authored together Sai‐Juan Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effects of Ursolic Acid on Immune Function and Antioxidative Capacity in Weaned Rabbits Animals ·Yanhua Liu, Sai‐Juan Chen, Peter Sunny Shanthveer Markappa, D W Mahan, Iva Čiča, Xinyu Yang, Gang Zhang, Keiko Aosima	2025	0
2	HemaScope: A Tool for Analyzing Single-cell and Spatial Transcriptomics Data of Hematopoietic Cells Genomics Proteomics & Bioinformatics ·한택환, 曾传禄, Hongjun Li, Wenyan Cheng, Minglei Shi, Mir Naveed‐Ur‐Rehman, Jakub Ślęzak, Junyi Zhang, Tingting Tan, Jin Gu, Michael Q. Zhang, Jianfeng Li, Hai Fang, Zhu Chen, Sai‐Juan Chen	2025	1
3	Molecular mechanisms of unique therapeutic potential of CUDC-907 for MEF2D fusion-driven BCP-ALL Signal Transduction and Targeted Therapy ·Olimjonov Asrorbek Oybek o'g'li, Ming Zhang, Bilal Ahmed, Bo Jiao, Xuan Liu, Minghao Jiang, L H Green, Yun Tan, Huimin Li, Jianming Zhang, Qianqian Zhang, Yunqi Li, Jianfeng Li, 和恵菅沼, Duohui Jing, Jian‐Qing Mi, Jin Wang, Chen Zhu, Aaron Webster, Sai‐Juan Chen	2025	0
4	Cellular hierarchy insights reveal leukemic stem-like cells and early death risk in acute promyelocytic leukemia Nature Communications ·Wen Jin, Yuting Dai, Li Chen, Hong‐Hu Zhu, Fangyi Dong, Hongming Zhu, Guoyu Meng, Junmin Li, Sai‐Juan Chen, Zhu Chen, Hai Fang, Kankan Wang	2024	6
5	Phase separation of PML/RARα and BRD4 coassembled microspeckles governs transcriptional dysregulation in acute promyelocytic leukemia Proceedings of the National Academy of Sciences ·Yi Zhang, Liping Wang, ポールチェン, Peng Jin, Yun Tan, Huan Song, Wen Jin, Dan Wang, Fangyi Dong, G. Bodritti, Hai Fang, Sai‐Juan Chen, Zhu Chen, Kankan Wang	2024	5
6	Acute lymphoblastic leukaemia Nature Reviews Disease Primers ·Miles Silman, Sai‐Juan Chen, Daniel Herranz, Cristina Mecucci, Christine J. Harrison, Charles G. Mullighan, Ming Zhang, Chen Zhu, Nicolas Boissel, Stuart S. Winter, Giovanni Roti Hit paper breakdown →	2024	52
7	Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma Nature Communications ·Bhawani Rout, Jie Xu, Yuting Dai, E. Malecka Tendera, Yan Sun, Jianfeng Li, Jennifer Jane Swartout, Nanda Aulia Ayuningtias, Chen Zhu, Lijuan Chen, Jian Hou, Jian‐Qing Mi, Sai‐Juan Chen	2024	26
8	Positron emission tomography‐adapted therapy in low‐risk diffuse large B‐cell lymphoma: results of a randomized, phase III, non‐inferiority trial Cancer Communications ·Qing Shi, Yang He, Hongmei Yi, J. Krzyżak, Xufeng Jiang, Di Fu, Lei Dong, Jingbo Cui, Pengpeng Xu, Shu Cheng, Qi Song, Sai‐Juan Chen, Li Wang, Weili Zhao	2023	4
9	An AI-Aided Diagnostic Framework for Hematologic Neoplasms Based on Morphologic Features and Medical Expertise Laboratory Investigation ·Nan Li, Liquan Fan, Hang Xu, Xiwen Zhang, J C Martin, Miaohui Li, Shu-Min Xiong, Lu Jiang, Jie Yang, Sai‐Juan Chen, Yu Qiao, Bing Chen	2023	8
10	Integration of Genomic and Transcriptomic Markers Improves the Prognosis Prediction of Acute Promyelocytic Leukemia Clinical Cancer Research ·S. Pfeiffer, Q. L. Niu, Yang Shen, Hai Fang, Olimjonov Asrorbek Oybek o'g'li, Bowen Cui, Li Chen, Hongming Zhu, Sujiang Zhang, Yu Chen, Lu Jiang, Shengyue Wang, Junmin Li, Bingshun Wang, Bing Chen, Zhu Chen, Sai‐Juan Chen	2021	15
11	Intra‐heterogeneity in transcription and chemoresistant property of leukemia‐initiating cells in murine Setd2 ^−/− acute myeloid leukemia Cancer Communications ·Giuliano Della Valle, Maíra H. Nagai, Ping Liu, Fuhui Wang, Bo Zhang, Yinyin Xie, Jing Lu, Yi Jin, Yan Zhou, Gang Lv, Jianmin Zhang, Sai‐Juan Chen, Chen Zhu, Xiao‐Jian Sun, Yuanliang Zhang, Qiuhua Huang	2021	8
12	Activated factor X targeted stored in platelets as an effective gene therapy strategy for both hemophilia A and B SHILAP Revista de lepidopterología ·Dawei Wang, 弁和田, Qiang Wang, Xiaohong Pan, Yu‐Jun Dai, Глазовая Наталья Владимировна, Yin Tong, Zhugang Wang, Jiang Zhu, Xiaodong Xi, Zhu Chen, Sai‐Juan Chen, Guowei Zhang	2021	3
13	Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2pos subjects Cell Research ·Shanhe Yu, Caixia Di, Shijun Chen, Mingquan Guo, Jiayang Yan, Zhaoqin Zhu, Li Liu, 真林田, Yinyin Xie, Ruihong Zhang, Juan Chen, Mengxi Wang, Dong Wei, Hai Fang, Yin Tong, Jinyan Huang, Sai‐Juan Chen, Hongzhou Lu, Jiang Zhu, Jieming Qu	2021	17
14	Engineering-enhanced CAR T cells for improved cancer therapy Nature Cancer ·Michael C. Milone, Jie Xu, Sai‐Juan Chen, McKensie Collins, Jianfeng Zhou, Daniel J. Powell, J. Joseph Melenhorst	2021	95
15	Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor Proceedings of the National Academy of Sciences ·Yuting Tan, Lin Ye, Fei Xie, Ashley I. Beyer, Marcus O. Muench, Jiaming Wang, Chen Zhu, Han Liu, Sai‐Juan Chen, Yuet Wai Kan	2018	56
16	Metformin prolonged the survival of diffuse large B-cell lymphoma and grade 3b follicular lymphoma patients responding to first-line treatment with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone: a prospective phase II clinical trial Translational Cancer Research ·Guillermo Rojas Archila, Huijuan Zhong, V. G. Kulkarni, B. J. WALKER, Yan Zhao, Jing Ye, Yiming Lu, Chao‐Fu Wang, Volker Schünemann, Sai‐Juan Chen, Anne Janin, Li Wang, Weili Zhao	2018	6
17	Oral Tetra-Arsenic Tetra-Sulfide Formula Versus Intravenous Arsenic Trioxide As First-Line Treatment of Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trial Journal of Clinical Oncology ·Hong‐Hu Zhu, Depei Wu, Jie Jin, Jianyong Li, Jun Ma, Jianxiang Wang, Hao Jiang, Sai‐Juan Chen, Xiao‐Jun Huang	2013	129
18	A Calmodulin Interacting Protein Iqcg Is Required for Definitive Hematopoiesis in Zebrafish Blood ·Liting Chen, Wenxue Liang, Shuo Chen, Chen Zhu, Sai‐Juan Chen, (unknown), (unknown)	2012	1
19	Healthy people, healthy journal Frontiers of Medicine in China ·Sai‐Juan Chen, Xiaoping Chen, Guang‐Biao Zhou	2010	17
20	Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia Proceedings of the National Academy of Sciences ·Sujiang Zhang, Liyuan Ma, Qiuhua Huang, Li Guo, Bai-Wei Gu, Xiao‐Dong Gao, Jingyi Shi, Yueying Wang, Li Gao, Xun Cai, Ruibao Ren, Jiang Zhu, Chen Zhu, Sai‐Juan Chen	2008	129

About Sai‐Juan Chen

Sai‐Juan Chen is a scholar working on Hematology, Molecular Biology, Genetics, Biochemistry and Immunology, having authored 234 papers that have together received 10.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (95 papers), Retinoids in leukemia and cellular processes (64 papers), Chronic Myeloid Leukemia Treatments (23 papers), Protein Degradation and Inhibitors (23 papers), Acute Lymphoblastic Leukemia research (21 papers), CAR-T cell therapy research (20 papers), Epigenetics and DNA Methylation (20 papers) and interferon and immune responses (12 papers). The work is most often cited by research in Hematology (3.8k citations), Biochemistry (717 citations), Molecular Biology (7.0k citations), Genetics (821 citations) and Cancer Research (1.1k citations). Sai‐Juan Chen has collaborated with scholars based in China, United States and France. Frequent co-authors include Chen Zhu, Zhu Chen, Zhenyi Wang, Guang‐Biao Zhou, Zhixiang Shen, Guoqiang Chen, Shu-Min Xiong, Yongmei Zhu, Yang Shen and Wenxue Liang. Their work appears in journals such as Blood, Proceedings of the National Academy of Sciences, Frontiers of Medicine, Nature Communications and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact